These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

692 related articles for article (PubMed ID: 31025705)

  • 1. Cln3-mutations underlying juvenile neuronal ceroid lipofuscinosis cause significantly reduced levels of Palmitoyl-protein thioesterases-1 (Ppt1)-protein and Ppt1-enzyme activity in the lysosome.
    Appu AP; Bagh MB; Sadhukhan T; Mondal A; Casey S; Mukherjee AB
    J Inherit Metab Dis; 2019 Sep; 42(5):944-954. PubMed ID: 31025705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ppt1-deficiency dysregulates lysosomal Ca
    Mondal A; Appu AP; Sadhukhan T; Bagh MB; Previde RM; Sadhukhan S; Stojilkovic S; Liu A; Mukherjee AB
    J Inherit Metab Dis; 2022 May; 45(3):635-656. PubMed ID: 35150145
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cln1-mutations suppress Rab7-RILP interaction and impair autophagy contributing to neuropathology in a mouse model of infantile neuronal ceroid lipofuscinosis.
    Sarkar C; Sadhukhan T; Bagh MB; Appu AP; Chandra G; Mondal A; Saha A; Mukherjee AB
    J Inherit Metab Dis; 2020 Sep; 43(5):1082-1101. PubMed ID: 32279353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cln1 gene disruption in mice reveals a common pathogenic link between two of the most lethal childhood neurodegenerative lysosomal storage disorders.
    Chandra G; Bagh MB; Peng S; Saha A; Sarkar C; Moralle M; Zhang Z; Mukherjee AB
    Hum Mol Genet; 2015 Oct; 24(19):5416-32. PubMed ID: 26160911
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of lysosomal nutrient sensing scaffold contributes to pathogenesis of a fatal neurodegenerative lysosomal storage disease.
    Bagh MB; Appu AP; Sadhukhan T; Mondal A; Plavelil N; Raghavankutty M; Supran AM; Sadhukhan S; Liu A; Mukherjee AB
    J Biol Chem; 2024 Feb; 300(2):105641. PubMed ID: 38211816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The novel Cln1(R151X) mouse model of infantile neuronal ceroid lipofuscinosis (INCL) for testing nonsense suppression therapy.
    Miller JN; Kovács AD; Pearce DA
    Hum Mol Genet; 2015 Jan; 24(1):185-96. PubMed ID: 25205113
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene.
    Sondhi D; Scott EC; Chen A; Hackett NR; Wong AM; Kubiak A; Nelvagal HR; Pearse Y; Cotman SL; Cooper JD; Crystal RG
    Hum Gene Ther; 2014 Mar; 25(3):223-39. PubMed ID: 24372003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Loss of CLN3, the gene mutated in juvenile neuronal ceroid lipofuscinosis, leads to metabolic impairment and autophagy induction in retinal pigment epithelium.
    Zhong Y; Mohan K; Liu J; Al-Attar A; Lin P; Flight RM; Sun Q; Warmoes MO; Deshpande RR; Liu H; Jung KS; Mitov MI; Lin N; Butterfield DA; Lu S; Liu J; Moseley HNB; Fan TWM; Kleinman ME; Wang QJ
    Biochim Biophys Acta Mol Basis Dis; 2020 Oct; 1866(10):165883. PubMed ID: 32592935
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A function retained by the common mutant CLN3 protein is responsible for the late onset of juvenile neuronal ceroid lipofuscinosis.
    Kitzmüller C; Haines RL; Codlin S; Cutler DF; Mole SE
    Hum Mol Genet; 2008 Jan; 17(2):303-12. PubMed ID: 17947292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
    Chan CH; Mitchison HM; Pearce DA
    Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intrathecal enzyme replacement therapy improves motor function and survival in a preclinical mouse model of infantile neuronal ceroid lipofuscinosis.
    Lu JY; Nelvagal HR; Wang L; Birnbaum SG; Cooper JD; Hofmann SL
    Mol Genet Metab; 2015; 116(1-2):98-105. PubMed ID: 25982063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathogenesis and therapies for infantile neuronal ceroid lipofuscinosis (infantile CLN1 disease).
    Hawkins-Salsbury JA; Cooper JD; Sands MS
    Biochim Biophys Acta; 2013 Nov; 1832(11):1906-9. PubMed ID: 23747979
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Compromised astrocyte function and survival negatively impact neurons in infantile neuronal ceroid lipofuscinosis.
    Lange J; Haslett LJ; Lloyd-Evans E; Pocock JM; Sands MS; Williams BP; Cooper JD
    Acta Neuropathol Commun; 2018 Aug; 6(1):74. PubMed ID: 30089511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuronal ceroid lipofuscinosis with DNAJC5/CSPα mutation has PPT1 pathology and exhibit aberrant protein palmitoylation.
    Henderson MX; Wirak GS; Zhang YQ; Dai F; Ginsberg SD; Dolzhanskaya N; Staropoli JF; Nijssen PC; Lam TT; Roth AF; Davis NG; Dawson G; Velinov M; Chandra SS
    Acta Neuropathol; 2016 Apr; 131(4):621-37. PubMed ID: 26659577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of the neuronal ceroid lipofuscinoses: mutations in CLN1, CLN2, CLN3, and CLN5.
    Mole SE; Mitchison HM; Munroe PB
    Hum Mutat; 1999; 14(3):199-215. PubMed ID: 10477428
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Neuroprotection and lifespan extension in Ppt1(-/-) mice by NtBuHA: therapeutic implications for INCL.
    Sarkar C; Chandra G; Peng S; Zhang Z; Liu A; Mukherjee AB
    Nat Neurosci; 2013 Nov; 16(11):1608-17. PubMed ID: 24056696
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Non-invasive assessment of retinal alterations in mouse models of infantile and juvenile neuronal ceroid lipofuscinosis by spectral domain optical coherence tomography.
    Groh J; Stadler D; Buttmann M; Martini R
    Acta Neuropathol Commun; 2014 May; 2():54. PubMed ID: 24887158
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antigen presenting cell abnormalities in the Cln3(-/-) mouse model of juvenile neuronal ceroid lipofuscinosis.
    Hersrud SL; Kovács AD; Pearce DA
    Biochim Biophys Acta; 2016 Jul; 1862(7):1324-36. PubMed ID: 27101989
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.
    Chandrachud U; Walker MW; Simas AM; Heetveld S; Petcherski A; Klein M; Oh H; Wolf P; Zhao WN; Norton S; Haggarty SJ; Lloyd-Evans E; Cotman SL
    J Biol Chem; 2015 Jun; 290(23):14361-80. PubMed ID: 25878248
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.